Vaccine development and testing, containment level 2 and 3 infectious disease research, large animal models of disease, preclinical trials, regulatory trials
VIDO-InterVac is one of Canada’s premier research institutes, with over 40 years of experience in infectious disease research and vaccine development for animals and humans. VIDO-InterVac has more than 150 personnel and some of the world’s most advanced containment infrastructure, including containment level 2 and level 3 animal housing and laboratories, a select agent lab, an aerobiology challenge unit, and a 160-acre containment level 2 research station. The unique $140-million large animal containment level 3 laboratory (the International Vaccine Centre or InterVac) became operational in 2013. VIDO-InterVac can complete multiple stages of vaccine development including pre-clinical trials for human vaccines and full regulatory and efficacy trials for animal vaccines.
Pathogenomics, proteomics, metabolomics, kinomics, antigen identification, vaccine development, vaccine formulation and delivery, animal disease models (containment 2 and 3), preclinical vaccine testing (human), regulatory vaccine testing (animals)
- Agriculture, animal science and food
- Defence and security industries
- Fisheries and aquaculture
- Healthcare and social services
Specialized labs and equipment
Specialized lab | Equipment | Function |
---|---|---|
Containment Level 2 (CL2) | 100,000 square feet of level 2 lab space and additional 20,000 square feet of level 2 animal isolation | |
Containment Level 3 (CL3)
|
18 CL3 animal suites (including aerobiology challenge units) that can accommodate most animal species. 6 CL3 laboratories. | |
Research station | 160-acre Research Station | Research station certified to containment level 2 able to conduct large animal studies including efficacy trials on horses and cattle. |
CL3 aerobiology laboratory | Madison Chamber, fully suited | Fully suited laboratory for aerobiology challenge experiments including Canada’s only Madison chamber for aerobiology challenge experiments. |
Select agent laboratory | Class 3 Glovebox | Provides infrastructure required to work with select agents as classified by the Federal Select Agent Program in the United States. |
Private and public sector research partners
- AbCelex Technologies
- Alberta Research Chemicals
- AnGes MG
- Boehringer Ingelheim
- Canadian Swine Health Board
- Elanco
- Guangzhou Institute of Respiratory Disease
- Guangzhou Yuanbo Medical Technology Co.
- Huvepharma
- Intervet Canada
- Kamada
- Konkuk University
- Lumen Associates
- Medicago
- Merck Animal Health
- Merial
- Ohio State University
- Phileo-Lesaffre Animal Care
- South China Vaccine Corporation
- SterileCare
- University of Alberta
- University of British Columbia
- University of Calgary